119 related articles for article (PubMed ID: 36065521)
1. Letter to the editor: Postvaccination COVID-19-related mortality in patients with cirrhosis: Who is the culprit?
Duan Z
Hepatology; 2023 Jan; 77(1):E13. PubMed ID: 36065521
[No Abstract] [Full Text] [Related]
2. Letter to the editor: Could COVID-19 vaccination reduce postinfection mortality in most patients with cirrhosis?
Lo GH
Hepatology; 2023 Feb; 77(2):E32. PubMed ID: 36053792
[No Abstract] [Full Text] [Related]
3. Letter to the editor: Reactivation of HBV triggered by SARS-CoV-2 in a patient with cirrhosis.
Librero Jiménez M; López Garrido MÁ; Fernández Cano MC
Hepatology; 2022 Mar; 75(3):765-766. PubMed ID: 34888903
[No Abstract] [Full Text] [Related]
4. COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis.
John BV; Bastaich DR; Ferreira RD; Doshi A; Taddei TH; Kaplan DE; Spector S; Deng Y; Dahman B
Gut; 2023 Sep; 72(9):1800-1802. PubMed ID: 36562753
[No Abstract] [Full Text] [Related]
5. Coronavirus disease 2019 (COVID-19) vaccination in patients with cirrhosis: Does it work?
Calleri A; Saracco M; Romagnoli R; Martini S
Hepatol Commun; 2022 Jun; 6(6):1502-1503. PubMed ID: 35429145
[TBL] [Abstract][Full Text] [Related]
6. Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma.
Pazgan-Simon M; Kucharska M; Górka-Dynysiewicz J; Simon K
Pharmacol Rep; 2022 Dec; 74(6):1306-1314. PubMed ID: 36394820
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection in patients with a normal or abnormal liver.
Cabibbo G; Rizzo GEM; Stornello C; Craxì A
J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
[TBL] [Abstract][Full Text] [Related]
8. Postvaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis.
John BV; Deng Y; Schwartz KB; Taddei TH; Kaplan DE; Martin P; Chao HH; Dahman B
Hepatology; 2022 Jul; 76(1):126-138. PubMed ID: 35023206
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis.
Kulkarni AV; Metage CS; Gora BA; Tirumalle S; Rakam K; Satyavadi A; Sharma M; Shaik S; Gujjarlapudi D; Rao PN; Reddy DN
Gut; 2023 Oct; 72(10):1995-1996. PubMed ID: 36113980
[No Abstract] [Full Text] [Related]
10. Letter regarding "High rates of 30-day mortality in patients with cirrhosis and COVID-19".
Medhat MA; El Kassas M
J Hepatol; 2020 Dec; 73(6):1569-1570. PubMed ID: 32574577
[No Abstract] [Full Text] [Related]
11. COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.
Cao Z; Zhang C; Zhao S; Sheng Z; Xiang X; Li R; Qian Z; Wang Y; Chen B; Li Z; Liu Y; An B; Zhou H; Cai W; Wang H; Gui H; Xin H; Xie Q
Infect Dis Poverty; 2022 May; 11(1):56. PubMed ID: 35578350
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 in patients with cirrhosis: understanding adverse impact.
Sharma S; Elhence A; Vaishnav M; Kumar R; Shalimar
Gut; 2021 Jul; 70(7):1409. PubMed ID: 32826307
[No Abstract] [Full Text] [Related]
13. Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.
Ge J; Pletcher MJ; Lai JC;
Gastroenterology; 2021 Nov; 161(5):1487-1501.e5. PubMed ID: 34284037
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.
Brozat JF; Hanses F; Haelberger M; Stecher M; Dreher M; Tometten L; Ruethrich MM; Vehreschild JJ; Trautwein C; Borgmann S; Vehreschild MJGT; Jakob CEM; Stallmach A; Wille K; Hellwig K; Isberner N; Reuken PA; Geisler F; Nattermann J; Bruns T;
United European Gastroenterol J; 2022 May; 10(4):409-424. PubMed ID: 35482663
[TBL] [Abstract][Full Text] [Related]
15. Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19.
Iavarone M; D'Ambrosio R; Lampertico P
Gut; 2021 Sep; 70(9):1798-1799. PubMed ID: 33028665
[No Abstract] [Full Text] [Related]
16. Letter to Editor in response to the article "Vitamin D insufficiency as a potential culprit in critical COVID-19 patients".
Khalili F; Yarani R; Haghgoo SM; Emami Aleagha MS
J Med Virol; 2021 Jul; 93(7):4081-4082. PubMed ID: 33656189
[No Abstract] [Full Text] [Related]
17. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study.
Afify S; Eysa B; Hamid FA; Abo-Elazm OM; Edris MA; Maher R; Abdelhalim A; Abdel Ghaffar MM; Omran DA; Shousha HI
World J Gastroenterol; 2021 Nov; 27(42):7362-7375. PubMed ID: 34876795
[TBL] [Abstract][Full Text] [Related]
18. High rates of 30-day mortality in patients with cirrhosis and COVID-19.
Iavarone M; D'Ambrosio R; Soria A; Triolo M; Pugliese N; Del Poggio P; Perricone G; Massironi S; Spinetti A; Buscarini E; Viganò M; Carriero C; Fagiuoli S; Aghemo A; Belli LS; Lucà M; Pedaci M; Rimondi A; Rumi MG; Invernizzi P; Bonfanti P; Lampertico P
J Hepatol; 2020 Nov; 73(5):1063-1071. PubMed ID: 32526252
[TBL] [Abstract][Full Text] [Related]
19. Increased Hepatic Expression of SARS-CoV-2 Entry Points and Proinflammatory Cytokines in Cirrhosis.
Limon-De La Rosa N; Cervantes-Alvarez E; Navarro-Alvarez N
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):239-241.e3. PubMed ID: 34481957
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort.
Bajaj JS; Garcia-Tsao G; Biggins SW; Kamath PS; Wong F; McGeorge S; Shaw J; Pearson M; Chew M; Fagan A; de la Rosa Rodriguez R; Worthington J; Olofson A; Weir V; Trisolini C; Dwyer S; Reddy KR
Gut; 2021 Mar; 70(3):531-536. PubMed ID: 32660964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
